Assessing the Benefits of Robotic and Laparoscopic Surgery for Mid and Low Rectal Cancer in Patients: The Charlson Comorbidity Index (CCI)

Daorong Wang505 enrolled

Overview

This retrospective study collected participants who underwent robotic or laparoscopic anterior resection for rectal cancer at the North People's Hospital in Jiangsu from January 2019 to January 2023.

Study Type

OBSERVATIONAL

Enrollment

505

Conditions

Robotic Laparoscopic Anterior Resection for Rectal Cancer

Interventions

robotic surgeryPROCEDURE

robotic surgery

laparoscopic surgeryPROCEDURE

laparoscopic surgery

Eligibility

Sex: ALLMin age: 55 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: The criteria include: (1) pathology of low rectal cancer (within 10 cm from the anal margin); (2) access to comprehensive pathological and computed tomography (CT) data; (3) completeness of clinical data. Exclusion Criteria: patients with other malignant tumors besides rectal cancer, benign disease surgery, and emergency surgery.

Locations (1)

Northern Jiangsu People's Hospital

Yangzhou, Jiangsu, China

Outcomes

Primary Outcomes

postoperative recurrence rate

Time frame: 2018-2024

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.